Mizuho maintains Arthur J. Gallagher at Outperform, raises price target to $307 from $302

Mizuho raised its price target for Arthur J. Gallagher to $307 from $302, implying a 10.7% upside from the Nov 12 close. The firm maintained its Outperform rating. Recent analyst targets range from $275 to $320.

Original reporting
Published Nov 13, 2026, 5:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 5:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Mizuho maintains Arthur J. Gallagher at Outperform, raises price target to $307 from $302 — source image
Decision brief

The 30-second read

$AJGBullishLow
01

Why it matters

This is primarily a sentiment and positioning input. Without new AJG fundamentals, it is unlikely to drive a large repricing by itself, but it can contribute to incremental bullish pressure and influence near-term analyst consensus.

02

Market read

A modest bullish analyst update for AJG, useful for tracking analyst flow and potential short-term sentiment, but not a standalone fundamental catalyst.

03

What to watch

Traders may discount the move if the broader market or peers are repricing risk/valuation, or if AJG’s next earnings/guidance contradicts the analyst’s assumptions.

Relevance 4/10Novelty 4/10Timing: as of the analyst note publication date, for positioning ahead of subsequent analyst flow

Background

The piece summarizes a single analyst action from Mizuho on Arthur J. Gallagher, including the prior and new price target and the implied upside versus the Nov 12 close.

Company-level read

Ticker impact

$AJGBullishMedium confidence
Context

Mizuho maintained Arthur J. Gallagher at Outperform and raised its price target to $307 from $302, implying ~10.7% upside from the Nov 12 close.

Expected impact

Likely mild upward bias as traders price in the higher target, with limited follow-through unless other catalysts emerge.

Evidence & confidence

The article contains only an analyst rating and price-target change, with no new AJG operational, financial, or regulatory disclosure.

Market effects

Minimal sector read-through; this is a single-name analyst target change in insurance brokerage.

None indicated.

None indicated.

Counterpoint

Price-target hikes often fade if they are not accompanied by new earnings, guidance, or material events; the implied upside may already be priced.

Key entities

  • Arthur J. Gallagher

    Insurance brokerage firm covered by Mizuho; maintained at Outperform with a raised price target to $307.

Related articles

$AJGMed

Why is Arthur J Gallagher stock sliding today?

Arthur J. Gallagher & Co. (AJG) stock fell 0.7% in pre-market trading after BMO Capital and Citi downgraded it to Market Perform and Neutral, respectively, citing valuation concerns. Both firms raised their price targets, with Citi setting it at $300. The stock trades near its 52-week high of $281.53. Insider selling and a risk-averse market also contributed to the decline. Jefferies and Wells Fargo maintained bullish outlooks with higher targets.

$AJGMed

BMO downgrades Arthur J. Gallagher stock rating on valuation

BMO downgraded Arthur J. Gallagher (NYSE:AJG) to Market Perform, raising its price target to $295. The firm cited valuation and AI-related market pressures. AJG's Q3 2026 earnings showed a revenue miss but a 25% net earnings growth. Analysts from Goldman Sachs and Keefe, Bruyette & Woods maintained positive outlooks with targets of $296 and $275, respectively.

$AJGMedAI 8/10

Arthur J. Gallagher & Co (AJG) (Q3 2026) Earnings Call Highlights: 26 Straight Quarters

Arthur J. Gallagher & Co reported Q3 2026 revenue growth of 18%, with net earnings and adjusted EBITDAC up 25%. Brokerage revenues rose 19%, while Risk Management grew 14%. M&A pipeline includes 30 term sheets for $300M in annualized revenue. Challenges include property premium declines and slower Employee Benefits growth. Management expects steady margin expansion and synergies from AssuredPartners.

$AJGMed

Goldman Sachs reiterates Arthur J. Gallagher stock rating on in-line Q3 results

Goldman Sachs maintained a Buy rating and $296 price target on Arthur J. Gallagher (AJG) after Q3 results. Adjusted EPS matched estimates at $3.00, but revenue missed expectations. Goldman lowered 2027 Brokerage growth estimate to 4.5% and adjusted revenue expectations. AJG's stock trades near its 52-week high with a P/E ratio of 44.58. Keefe, Bruyette & Woods raised its price target to $275, citing higher adjusted EBITDAC margins.

$AJGMed

Gallagher’s 5% organic growth looks modest - until you compare it with the competition

Arthur J. Gallagher & Co. reported 5% organic growth in Q3, with revenues of $3.93B and adjusted EPS of $3.00. CEO J. Patrick Gallagher Jr. highlighted the strength of their diversified model. Compared to peers, Gallagher's growth appears modest, but its focus on broking may be advantageous in a softening market. The company completed five acquisitions in Q3, adding $102M in annualized revenues.